Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Perini

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Plos Genetics|June 24, 2011
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityGlenn M Marshall, Pei Y Liu, Samuele Gherardi, et al.
Nature Communications|June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaLing Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Cancer Research|February 18, 2017
The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene TranscriptionMatthew Wong, Andrew E L Tee, Giorgio Milazzo, et al.
Cancer Research|May 20, 2016
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.
American Journal of Human Genetics|January 8, 2011
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2Tommaso Pippucci, Anna Savoia, Silverio Perrotta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2021
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic ReprogrammingLing Tao, Myrthala Moreno-Smith, Rodrigo Ibarra-García-Padilla, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
Systematic Targeting of GD2-Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector PlatformSuleman Khan Zadran, Nicola Facchinello, Piergiuseppe De Rosa, et al.
Cancer Research|October 17, 2015
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in NeuroblastomaYuting Sun, Jessica L Bell, Daniel Carter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated responseRuby Pandher, Chengyuan Xue, Laura D Gamble, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Plos Genetics|June 24, 2011
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityGlenn M Marshall, Pei Y Liu, Samuele Gherardi, et al.
Nature Communications|June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaLing Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Cancer Research|February 18, 2017
The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene TranscriptionMatthew Wong, Andrew E L Tee, Giorgio Milazzo, et al.
Cancer Research|May 20, 2016
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.
American Journal of Human Genetics|January 8, 2011
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2Tommaso Pippucci, Anna Savoia, Silverio Perrotta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2021
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic ReprogrammingLing Tao, Myrthala Moreno-Smith, Rodrigo Ibarra-García-Padilla, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
Systematic Targeting of GD2-Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector PlatformSuleman Khan Zadran, Nicola Facchinello, Piergiuseppe De Rosa, et al.
Cancer Research|October 17, 2015
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in NeuroblastomaYuting Sun, Jessica L Bell, Daniel Carter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated responseRuby Pandher, Chengyuan Xue, Laura D Gamble, et al.
Pageof 8